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ABSTRACT: A 38-year-old white female, hepatitis B antigen negative, 
developed iluminating hepatic failure associated with oliguria and severe 
azotemia after two halothane anesthesia and without exposure to other 
hepatotoxic drugs or blood transfusions. She was treated with multiple 
hemodialysis and exchange blood transfusion. The combined treatment 
corrected the uremic abnormalities and improved her level of consciousness. 
The liver and kidney function gradually improved, and she made a complete 
recovery, the first recorded with hepatic and renal failure under these post-
anesthetic conditions. Further evaluation of this combined treatment used for 
this patient is warranted. 
KEY WORDS: halothane hepatitis, renal failure, hemodialysis, exchange 
transfusion. 
INTRODUCTION 
Halothane induced liver injury with coma almost invariably leads to death. The 
occurrence of oliguria in the presence of severe hepatic insufficiency is a further poor prog-
nostic sign2•5 ,8. No survival has been reported in patients wilh halothane induced hepatic 
necrosis with oliguria. We have recently treated a 38-year-old Caucasian female WIth 
severe halothane hepatitis with coma and oliguria, who recovered from the two abnor-
malities following hemodialysis and exchange transfusion. It is the purpose of the present 
communication to describe the management of this patient, which may be of potential 
benefit for the treatment of patients with similar diseases. 
CASE REPORT 
A S8-year-old obese Caucasian female underwent two laparotomies without blood 
transfusion on November 9, 1972 and January 3, 1973 because of a malignant lesion of 
the left ovary. Anesthesia was with halothane and nitrous oxide on both occasions. By 
palpation, the liver and the gallbladder were described as normal both times. The post-
operative course was uneventful after the first operation. After the second laparotomy, 
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Fig. 1. The change in scrum concentration of BUN. Bilirubin, prothrombin time 
and daily urine volume in patient S.T. during the hospital course. 
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she developed low grade fever on the first and second postoperative days and became jaun-
diced and somewhat lethargic on the fifth day. The laboratory findings around this time 
revealed total bilirubin 13.7 mg/lOO m1, SGOT 4020 IU /L, prothrombin time 25 seconds 
(not improved with Vitamin K). On the 11 th day, the patient had an episode of hypoten-
sion lasting less than one hour. However, the urinary output did not decrease during the 
next three days. By the 13th day, she became more lethargic with asterixis and slurring of 
speech. An abrupt decrease of serum hepatic enzymes (SGOT 562, SGPT 712) with the 
presence of very low BUN (Figure 1) and increasing bilirubin and prothrombin time were 
consistent with fulminating hepatic necrosis. The patient was, therefore, transferred on the 
16th day to Colorado General Hospital for further evaluation and possible liver trans-
plantation. On arrival, the patient was lethargic and had pronounced asterixis plus nausea 
and vomiting. Urinalysis on admission revealed pH 5, specific gravity 1.027. Urinary Na 
was 12 mEq/L. The sediment showed 1-5 granular cast and rare WBC, occasional RBC 
per high power field. Additional laboratory data showed: BUN 14 mg per cent, creati-
nine 4.1 mg/lOO ml, normal serum electrolytes and glucose, prothrombin time 15.5 per 
cent, bilirubin 30 mg/lOO ml, SGOT 52, SGPT 99, alkaline phosphatase 99 IU. The size 
of the liver was decreased, both on percussion and on radiotechnetium scan. Rose Bengal 
retention was 92 per cent Enormal=R~11 per cent). The patient's urine volume decreased 
markedly following admission. On the 19th day, the BUN was 92 and serum creatinine 
10.0 mg/lOO m!. A Schribner type arteriovenous shunt was inserted in the patient's right 
forearm. Hemodialysis was performed with regional heparinization with DOW-4 hollow 
fiber dialyzer (see Figure 1). However, the patient's level of consciousness continued to 
deteriorate. On the 28th day, the patient lapsed into the fourth stage of hepatic coma. 
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Exchange transfusions were performed through the A-V shunt with heparinized whole 
blood (10 units). After this procedure, the bilirubin decreased and the urine output began 
to increase. The patient showed an improvement in the level of consciousness about 24 
hours after the procedure. On the 31st day, the liver scan revealed definitive increase in 
size. Urinary output also showed a further increase. The hemodialysis was, therefore, dis-
continued. The prothrombin time and the bilirubin continued to improve gradually. The 
kidney function as estimated by creatinine clearances also showed gradual improvement, 
reaching 10 ml/min on the 49th day after the second laparotomy. The patient was dis-
charged the same day in good general condition. In October, 1973, the patient was asymp-
tomatic with a creatinine clearance of 60 ml/min. Hepatic enzymes and bilirubin were 
normal. Rose Bengal retention was 50 per cent. 
DISCUSSION 
Although halothane hepatitis is a well established clinical entity, arriving at a defini-
tive diagnosis may be difficult1. The exclusion of other etiological factors is necessary before 
the role of the halothane as the pathogenetic agent may be assumed. In our patient, the 
following findings supported the diagnosis of halothane hepatitis. First, normal consistency 
of the liver on palpation during the two laparotomies made pre-existing chronic liver 
disease unlikely. Second, the tests for Australia antigen were always negative, and the 
patient never received blood transfusions before the hepatic failure appeared. Third, this 
patient was exposed to halothane on two occasions, in less than two months' interval. 
She was obese and middle-aged, factors considered favorable for the development of halo-
thane hepatitis 1. 
The etiology of renal failure in this patient was not clear. Two major alternative 
possibilities were considered. The first was that functional renal failure was secondary to 
hepatic failure (hepatorenal syndrome). The second was that tubular necrosis either result-
ed from toxic insult to the kidney (possibly due to fluoride in the anesthetic agent) or was 
due to hypotension. However, there was no decrease in urinary output during the subse-
quent 3 postanesthetic days. This observation, plus a high urinary specific gravity (1.027) 
and a low urinary Na (12 mEq/L) on admission, militated against the diagnosis of acute 
tubular necrosis. Thus, the diagnosis of functional renal failure was held most likely. 
The reports on success with hemodialysis alone in hepatic failure are conflicting3,4, 
7,10. Although ammonia may be effectively removed with hemodialysis, the role of ammo-
nia in hepatic coma is not clearly defined7• In our patient, hemodialysis produced an 
improvement in the biochemical abnormalities of uremia, but it failed to alter the severity 
of the hepatic coma. The improvement in the state of consciousness as well as the increase 
in urine volume seemed to follow the exchange transfusion with 5 liters of blood. There 
have been some reports that exchange transfusion was effective for hepatic coma9• How-
ever, the efficacy of this procedure in acute hepatic failure has been seriously questioned 
in a recent report l . Thus, we cannot exclude a spontaneous and coincidental improvement 
in our case. 
In chronic hepatic failure, supportive treatment yields only temporary improvement 
and the prognosis is invariably poor. By contrast, in acute hepatic failure with potential 
reversal of liver damage, especially when complicated by renal failure, hemodialysis 
combined with exchange transfusion is worth trying. The presence of external arteriovenous 
shunt in our patient made the exchange transfusion a very easy and safe procedure, which 
could be repeated if necessary. A single case does not allow the drawing of definitive con-
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elusions, but the experience suggests that further evaluation of the combined treatment 
may be warranted. 
(Received for publication on Decmber 5, 1974) 
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